Glucosylceramide

Europe PMC · from cache · sorted by publication date

1. 1
   <i>Lactobacillus johnsonii</i> mediates the protective effects of pristimerin against ulcerative colitis and concomitant liver injury through remodeling hepatic lipid metabolism via LXRα-SCD1 axis.

   Cheng Y, Wu ZE, Huang R, Li Q, Yan D, Chen Y, Zhu W, Li F. · 2026-07-17

   unreviewed
2. 2
   Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib.

   Huang F, Zhan P, Shi X, Sun Y, Song X, Sun P, Liu B. · 2026-05-22

   open access unreviewed
3. 3
   Leucine-rich repeat kinase 2 (LRRK2): balancing cellular homeostasis and Parkinson's disease (PD) pathogenesis.

   Aolymat I, Abu-Hassan DW, Oleimat AK, Sameer W, Wreikat B, Iqilan T, Al-Momani H, Ali H, Tahtamouni L, Iqsair… · 2026-06-03

   open access unreviewed
4. 4
   The plasma metabolome and clinical features of patients with coeliac disease in Northwest China.

   Zhang W, Wu X, Li Y, Huang Z, Hui W, Shi T, Lu W, Bai H, Wu Q, Wang M, Liu K, Xu L, Gao F, Wu J. · 2026-05-16

   open access unreviewed
5. 5
   Beyond spherical vesicles: morphological diversity of extracellular vesicles in health and disease.

   Velázquez-Cervantes MA, Fierro NA, Lozano-Hernández R, Carrero JC. · 2026-05-04

   open access unreviewed
6. 6
   Metabolomic profiling of neat uterine luminal fluid in cows: local enrichment and nutritional modulation.

   Sagheer M, Hoorn QA, Maldonado MB, Schalich KM, Ashrafi N, A Mimi R, Graham SF, Selvaraj V, Hansen PJ. · 2026-01-07

   cited 3× open access unreviewed
7. 7
   Investigating FTY720-NF immunomodulation of key lipid, gene, and protein mediators to enhance oral tissue regeneration.

   Toma AI, Shah DC, Duke VR, Chiappa NF, Chinniampalayam Sekar KP, Cha T, Kamalakar A, Wood LB, Botchwey EA, Wi… · 2026-05-19

   unreviewed
8. 8
   Interplay of GBA1 with lysosomal dysfunction and inflammation in Parkinson's disease.

   Wang R, Hatano T, Hattori N, Cossu D. · 2025-12-30

   cited 2× unreviewed
9. 9
   Artesunate directly targets glucosylceramidase to suppress hepatocellular carcinoma proliferation and trigger apoptosis.

   Mao X, Yan X, Chen Y, Cai B, Chen W, Lin Y, Lin N, Zhang Y. · 2026-01-20

   open access unreviewed
10. 10
    Pathophysiological mechanisms of organ injury in Fabry disease: Update via multi-omics.

    Wei Z, Yang J, Han Z, Zhang X, Wang B. · 2025-11-25

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.